comprehensive
Previous article:
Wildfire smoke exposes gaps in outdoor worker protections
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
Next article: Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
explore
explore
-
Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more
2025-10-02 12:21 -
Coloradans with cystic fibrosis could lose access to Trikafta
2025-10-02 11:34 -
Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
2025-10-02 11:25 -
Gene therapy’s promise and the high cost of hope
2025-10-02 10:41 -
Live blog: Hearing on CRISPR
2025-10-02 10:23 -
BioAge raises $170M for combination therapy with Zepbound
2025-10-02 10:21